Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Lidocaine for Postoperative Recovery in Children with Peritonitis
NCT06051630Unknown
- Sponsor
- Université Nazi Boni
- Start
- Oct 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain and postoperative ileus (POI) (2 arms), sponsored by Université Nazi Boni. Primary endpoint: Resumption of bowel transit at 7 days. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative painpostoperative ileus (POI)
Beyond the preview
Go deeper on NCT06051630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06051630.